Disposition kinetics of human epidermal growth factor (hEGF1-53) and its truncated fragment (hEGF1-48) in rats

Drug Metabolism and Disposition

Volumn 24, Issue 1, 1996, Pages 96-104

  Kuo, Be Sheng ^a   Nordblom, Gerald D ^a   Dudeck, Richard C ^a   Kirkish, Lorraine S ^a   Scott Wright, D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; PENTAPEPTIDE; POLYSORBATE 20; POLYSORBATE 80; RECOMBINANT EPIDERMAL GROWTH FACTOR; SERUM ALBUMIN; UROGASTRONE;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CARBOXY TERMINAL SEQUENCE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DISPOSITION; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRAVENOUS DRUG ADMINISTRATION; LYSOSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; EPIDERMAL GROWTH FACTOR; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR;

ANIMALIA;

EID: 0030064114     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. S. Cohen and J. M. Taylor: Epidermal growth factor: chemical and biological characterization. Recent Prog. Harm. Res. 30, 533-550 (1974).
2. J. B. Elder, P. C. Ganguli, and I. E. Gillespi: Effect of urogastrone on gastric secretion and plasma gastrin. Gut 16, 887-903 (1975).
3. H. Gregory and I. R. Wilshire: The isolation of the urogastrone inhibitors of gastric acid secretion from human urine. Hoppe-Seyler's Z. Physiol. Chem. 356, 1765-1774 (1975).
4. H. Gregory. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 257, 325-327 (1975).
5. H. Carpenter and M. I. Wahe: The epidermal growth factor family. In "Peptide Growth Factors and Their Receptors" (M. B. Sporn and A. B. Roberts, eds.), vol. I, pp. 69-171. Springer-Verlag, New York. 1991.
6. T. Murakami, M. Kishimoto, Y. Higasi, H. Amagase, T. Hayashi, T. Fuwa, and N. Yata: Down-regulation and its effect of epidermal growth factor receptors on the pharmacokinetics of human epidermal growth factor after i.V. administration in rats. In:. J. Pharmaceut. 54, 259-267 (1989).
7. L. J. Pike: Dimer formation and desensitization of the epidermal growth factor. J. Lab. Clin. Med 120, 688-692 (1992).
8. S. Y. Shin, M. Shimizu, T. Ohtak, and E. Munekata: Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF). Peptides 16, 205-210 (1995).
9. R. J. Simpson, J. A. Smith, R. L. Moritz, M. J. O'Hare, P. S. Rudland, J. R. Morrison, C. J. Lloyd, B. Grego, A. W. Burgess, and E. C. Nice: Rat epidermal growth factor complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro activity. Eur. J. Biochem. 153, 629-637 (1985).
10. P. Lollar and W. Y. Owen: Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. J. Clin. Invest. 66, 1222-1230 (1980).